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http://arthritis-research.com/content/16/3/R121RESEARCH ARTICLE Open AccessAcid-sensing ion channel 3 decreases
phosphorylation of extracellular signal-regulated
kinases and induces synoviocyte cell death by
increasing intracellular calcium
Weiyi Gong1,2, Sandra J Kolker2, Yuriy Usachev3, Roxanne Y Walder2, David L Boyle4, Gary S Firestein4
and Kathleen A Sluka2*Abstract
Introduction: Acid-sensing ion channel 3 (ASIC3) is expressed in synoviocytes, activated by decreases in pH, and
reduces inflammation in animal models of inflammatory arthritis. The purpose of the current study was to characterize
potential mechanisms underlying the control of inflammation by ASIC3 in fibroblast-like synoviocytes (FLS).
Methods: Experiments were performed in cultured FLS from wild-type (WT) and ASIC3-/- mice, ASIC1-/- mice, and
people with rheumatoid arthritis. We assessed the effects of acidic pH with and without interleukin-1β on FLS and the
role of ASICs in modulating intracellular calcium [Ca2+]i, mitogen activated kinase (MAP kinase) expression, and cell
death. [Ca2+]i was assessed by fluorescent calcium imaging, MAP kinases were measured by Western Blots; ASIC,
cytokine and protease mRNA expression were measured by quantitative PCR and cell death was measured with a
LIVE/DEAD assay.
Results: Acidic pH increased [Ca2+]i and decreased p-ERK expression in WT FLS; these effects were significantly smaller
in ASIC3-/- FLS and were prevented by blockade of [Ca2+]i. Blockade of protein phosphatase 2A (PP2A) prevented the
pH-induced decreases in p-ERK. In WT FLS, IL-1β increases ASIC3 mRNA, and when combined with acidic pH enhances
[Ca2+]i, p-ERK, IL-6 and metalloprotienase mRNA, and cell death. Inhibitors of [Ca
2+]i and ERK prevented cell death
induced by pH 6.0 in combination with IL-1β in WT FLS.
Conclusions: Decreased pH activates ASIC3 resulting in increased [Ca2+]i, and decreased p-ERK. Under inflammatory
conditions, acidic pH results in enhanced [Ca2+]i and phosphorylation of extracellular signal-regulated kinase that leads
to cell death. Thus, activation of ASIC3 on FLS by acidic pH from an inflamed joint could limit synovial proliferation
resulting in reduced accumulation of inflammatory mediators and subsequent joint damage.Introduction
Acid-sensing ion channels (ASICs) are the primary acid
sensors in nociceptors, and substantial work shows that
activation of acid sensing ion channels (ASIC1, ASIC3)
contributes to the development of musculoskeletal pain
[1-8]. However, we previously demonstrated localization
of ASIC3 protein to Type B synoviocytes in mouse joint,
and ASIC3 protein and mRNA in cultured fibroblast-* Correspondence: kathleen-sluka@uiowa.edu
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unless otherwise stated.like synoviocytes (FLS) [6,9]. Acidic pH in cultured FLS
increases (Ca2+)i, and facilitates release of hyaluronic
acid; these pH-dependent effects are reduced in FLS
from ASIC3-/- mice [9].
Rheumatoid arthritis (RA) is a systemic inflammatory
disease that particularly affects synovial joints. Acidic pH
is associated with inflammation in rheumatoid joints
where pH drops between pH 6.0 and 7.0 [10,11]. ASIC3
senses decreases in pH within the physiological range that
would normally be found within an inflamed joint (pH 6.0
to 7.0) [5,12]. In RA, synoviocytes are key players in the
production of inflammatory mediators and proteases thattd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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damage [13-17]. Surprisingly, we found that ASIC3-/-
mice have enhanced inflammation, despite reduced pain
behaviors, in the collagen-induced arthritis model [1]. The
enhanced inflammation is accompanied by increased joint
destruction and inflammatory mediator production [1]. As
inflammatory mediators and decreases in pH occur simul-
taneously in inflammatory arthritis, we further tested the
effects of combining acidic pH with IL-1β - this combin-
ation results in cell death [1]. Thus, ASIC3 appears to play
a protective role in joints. Although ASIC1 is expressed in
FLS, the role of ASIC1 in FLS is unclear.
Increases in (Ca2+)i have multiple effects on cells includ-
ing modulation of intracellular messengers and promotion
of cell death. The intracellular signaling molecules
mitogen-activated protein kinases (MAPKs) in FLS are
critical players in the inflammatory process in RA. MAPKs
are activated by cytokines and Toll-like receptors in
human FLS with a subsequent positive feedback loop that
enhances expression of inflammatory cytokines [16-20].
For example, the MAPK c-Jun N-terminal kinase (JNK)
increases MMP3 gene expression to increase cellular
matrix degradation, which results in joint destruction
[18,20-22]. JNK2-/- mice have modestly lower cartilage
destruction, and inhibition with a non-specific JNK antag-
onist reduces expression and release of inflammatory cyto-
kines [19,22]. MAPK activation, including extracellular
signal-regulated kinase (ERK), JNK, and p38, can result in
cell death in a variety of cell types including neurons, can-
cer, chondrocytes, and macrophages [23-26]. Interestingly,
increased (Ca2+)i enhances PP2A catalytic subunit expres-
sion which results in decreased ERK phosphorylation [27].
It is, therefore, possible that low pH activates ASIC3 to in-
crease (Ca2+)i, which in turn reduces MAPK activation
and promotes cell death. The purpose of the current study
was to characterize potential mechanisms underlying the
control of inflammation by ASIC3 in FLS, compared to
wild-type (WT) and ASIC1 FLS. Specifically we tested if
(1) ASIC1 and ASIC3 mediate acidic pH-induced in-
creases in (Ca2+)i in FLS; (2) acidic pH changes phosphor-
ylation and expression of MAPK through ASIC1 and
ASIC3; (3) effects of pH on (Ca2+)i and MAPK are
enhanced in the presence of the inflammatory cytokine
IL-1β, and (4) increases in (Ca2+)i drive the changes in
MAPK activity and cell death.
Methods
Mice
C57Bl/6 J mice (WT), and congenic ASIC3-/- and
AISC1-/- mice on a C57B1/6 J background were bred at
the University of Iowa or the University of California San
Diego Animal Care Facility. The ASIC3-/- and ASIC1-/-
mice strains have been previously described and character-
ized in multiple studies [7,8,28,29]. Male mice, 9 to10 weeks of age, were used in these studies. All experi-
ments using animals were approved by Animal Care and
Use Committee at the University of Iowa and the University
of California San Diego, and conducted in accordance
with National Institutes of Health (NIH) guidelines. Use
of synoviocytes from human subjects was approved by the
Institutional Review Board in the Human Subjects Office
at the University of Iowa and in the Human Subjects Pro-
tection Program at the University of California San Diego.
Fibroblast-like synoviocyte (FLS) isolation and culture
Preparation of FLS from mice
FLS were isolated from WT, ASIC3-/- and ASIC1-/- mice
according to previously published methods [14,19]. Mice
were euthanized with sodium pentobarbital (100 mg/kg, ip)
and the limbs excised above the knee and elbow joints.
After rinsing the excised limbs in ethanol, the knee, ankle
and elbow joints were stripped of muscle and tendon. The
remaining bone and tissue were finely minced and
incubated in 0.5 mg/ml Type VIII collagenase (Sigma, St.
Louis, MO, USA) in RPMI (Invitrogen, Carlsbad, CA,
USA) at 37°C for 2 h. The tissue was pelleted at 1,200 rpm
and the supernatant discarded. The pellet was rinsed
twice in high-glucose DMEM (Gibco, Invitrogen, Carls-
bad, CA, USA) supplemented with penicillin, strepto-
mycin, 10% FBS, and 0.5% gentamycin (Cellgro, Manassas,
VA, USA), resuspended, plated onto T75 culture flasks
and incubated at 37°C with 5% CO2. FLS were grown until
>80 to 90% confluent before passaging. FLS were at pas-
sage 3 to 4 for use in western blot, (Ca2+)i, mRNA expres-
sion studies, and Live/Dead assays.
Preparation of human synovial tissue and FLS
This study was approved by the Institutional Review Board
of University of California, San Diego School of Medicine
and informed consent was obtained from all participants.
Synovial tissue was obtained from patients with RA at
the time of total joint replacement or synovectomy as
previously described. The diagnosis of RA conformed
to American College of Rheumatology 1987 revised criteria.
The samples were processed for cell culture. The synovium
was minced and incubated with 1 mg/ml collagenase type
VIII (Sigma) in serum-free RPMI 1640 (Gibco BRL, Grand
Island, NY, USA) for 1 h at 37°C, filtered, extensively
washed, and cultured in DMEM (Gibco BRL) supple-
mented with 10% FBS (Gemini Bio Products, Calabasas,
CA, USA), penicillin, streptomycin, gentamicin, and glu-
tamine, in a humidified 5% CO2 atmosphere. Cells were
allowed to adhere overnight, non-adherent cells were re-
moved, and adherent FLS were split at 1:3 when 70 to 80%
confluent. FLS were used from passage 3 through 9 during
which time they are a homogeneous population of cells
(<1% CD11b-positive, <1% phagocytic, and <1% FcγRII-
and FcγRIII-receptor-positive). FLS were cultured and
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0.1% FBS for 24 h before the addition of the appropriate
stimulus.
Calcium imaging
External physiological pH solutions used for Ca2+ im-
aging contained 120 mM NaCl, 5 mM KCl,1 mM MgCl2,
2 mM CaCl2, 10 mM HEPES, and 10 mM MES; the pH
of each solution was adjusted with tetramethylammo-
nium hydroxide, and osmolarity was adjusted with tetra-
methylammonium chloride [30]. Cells were plated at
30,000 cells/dish in poly-L-lysine (Sigma) coated 35-mm
glass-bottom petri dishes (MatTek Corp., Ashland, MA,
USA), and grown for 24 h in 10% FBS, antibiotic-
supplemented DMEM and subsequently serum-starved
(0.1% FBS, antibiotic-supplemented DMEM) 24 h prior
to testing.
After rinsing with pH 7.4 external buffer, cells were
loaded with the Ca2+-sensitive fluorescent indicator Ore-
gon Green BAPTA-1 AM (OGB-1) (Invitrogen, 8 μg/ml
(made from a 2.5 μg/μl DMSO stock), containing
0.013% pluronic F-127, (Invitrogen, diluted from a 20%
DMSO stock) in pH 7.4, 1 h, room temperature) as we
previously described [9]: 10 ml of pH and treatment so-
lutions were introduced into the culture dish at a rate of
100 μl/s through a syringe pump (Harvard Apparatus
PHD2000, Holliston, MA). Solution was simultaneously
removed from the opposite side of the dish by vacuum
aspiration.
Fluorescence was measured on a 150-s time course be-
fore, during, and after application of pH solutions. An
Olympus IX81 motorized inverted microscope and inte-
grated Intelligent Imaging Innovation’s Slidebook soft-
ware, v.4.1 was used to capture images. Analysis was
done using Image J (NIH) to measure the change of in-
tensity in a constant, defined area of the cell during each
pH application. Each session started with pH 7.4 infu-
sion for 20 s, followed by 2 minutes of acidic pH. Be-
tween pH solutions, pH 7.4 was again infused. All pH
solutions were applied in increasing acidic pH to each
culture dish with pH 7.4 infused between each solution.
Percent change in (Ca2+)i was quantified using the
formula:
%ΔF ¼ F‐F0ð Þ=F0  100;
where F is the fluorescence intensity at any given time
point and F0 is fluorescence intensity under control con-
ditions (pH = 7.4, calculated by averaging the intensities
recording during the first 20s of each time course). The
area under the curve during the 2-minute time period
was calculated using the percent-change scores; zero
represented no change in area and a positive number
represented an increase in calcium intensity.For Ca2+-free pH solutions calcium chloride was elimi-
nated from the external buffers and NaCl adjusted os-
molarity to 123 mM. For (Ca2+)i blockade, 30 μM
cyclopiazonic acid (CPA, Sigma-Aldrich) was added to the
cultures after OGB-1 loading, 5 minutes prior to Ca2+
imaging (12 μM CPA was included in treatment during
Ca2+imaging). In the IL-1β study, 1 ng/ml IL-1β (R and D
Systems, Minneapolis, MN, USA) was included in 0.5%
FBS serum-starved media 24 h prior to Ca2+ imaging.
Two cell culture lines were used for testing FLS from
the WT, ASIC3-/- and ASIC1-/-, Ca2+source study, and
the IL-1β study. Two cell cultures lines from control (for
example, WT) and experimental groups (for example,
ASIC1-/-) were always run on the same day to control
for differences due to loading or imaging. The profiles of
percent change (% Δ) as a function of time for all viable
cells in a group were averaged and compared, taken as a
percent change from the WT average at pH 5 or com-
pared to maximum intensity for each cell.
Amiloride (100, 250, 500 μM; Sigma) was added to
cultured human FLS, after OGB-1 loading, 10 minutes
prior to and during calcium imaging. Percent change in
(Ca2+)i was quantified using the formula:
%ΔF ¼ F‐F0ð Þ=F0  100;
where F is the fluorescence intensity at any given time
point and F0 is fluorescence intensity under control con-
ditions. Three cell culture lines were used for RA FLS
study under each condition.
Quantitative real-time polymerase chain reaction (qPCR)
FLS were plated at 100,000 cells/well in a 6-well tissue cul-
ture plate and grown for 24 h in 10% FBS/DMEM at 37°C
with 5% CO2 and subsequently incubated in 0.5% FBS/
DMEM for 24 h with or without 2 ng/ml IL-1β (Calbio-
chem, San Diego, CA, USA). FLS were then incubated in
0.5% FBS/DMEM pH 7.4 or pH 6.0 for 24 h. Cells were
then lysed in RNA STAT-60 (Tel-Test, Friendswood, TX,
USA). FLS RNA isolation and qPCR was performed as
previously described [31]. Using cDNA, mRNA expression
of IL-6, metalloproteinases (MMPs) and ASICs was mea-
sured by TaqMan Gene Expression Assay (Applied Biosys-
tems). The threshold cycle (Ct) values were used to
calculate the number of cell equivalents using a standard
complementary DNA curve as previously described [31].
The data were normalized to the expression of HPRT
(hypoxanthine guanine phosphoribosyltransferase) and
the results were expressed as relative expression units.
We examined mRNA expression for IL-6, MMP-3 and
MMP-13 from WT and ASIC3-/- FLS with and without
treatment with IL-1β (n = 3 preparations/group), and
for ASIC3 and ASIC1 in WT FLS with and without IL-
1β at pH 7.4 (n = 4 preparations/group). Different cell
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WT, ASIC3-/-).
Western blot analysis
FLS were plated in six-well plates at 200,000 cells/well,
and grown 24 h and then incubated in 0.1% FBS/DMEM
for 24 h before addition of stimulating factors. Western
blot analysis was performed as described previously [5].
After treatments (see below), protein was extracted with
lysis buffer (50 mM HEPES, 150 mM NaCl, 25 mM
MgCl2, 1 mM EDTA, 10% Glycerol, 1% tritonX-100,
20mMβ-glycerophosphate, 10 mM NaF, 1 mM Na3VO4,
supplemented with Complete Proteinase inhibitors (Roche
Applied Science, Indianapolis, IN, USA)) and protein con-
centration determined using the Micro BCA Protein
Assay Kit (Thermo Scientific, Rockford, IL, USA). Samples
containing 25 μg of protein were resolved on Invitrogen
NuPAGE 4% to 12% Bis Tris gels and transferred to a
polyvinylidene fluoride (PVDF) membrane. The mem-
branes were blocked with 5% non-fat milk, incubated
with primary Ab (all from Cell Signaling Technology,
Boston, MA, USA) at 4°C overnight, followed by horse-
radish peroxidase-conjugated secondary Ab for 1 h.
Membranes were developed and imaged using the UVP
Bioimaging systems and density of the band was quanti-
fied using Image J software (NIH). β-actin was used as a
loading control and used as an internal control, and all
blots were normalized to β-actin. Data were normalized
to the response at pH 7.4. All western blot data analyzed
included controls and experimental data for each condi-
tion. Data are expressed as the ratio compared to the
control. Each blot contained three replicates of control
and three replicates of experimental conditions. Each
control and experimental condition was run in three
separate primary cell cultures for a total of nine prepa-
rations for each condition (n = 9/condition).
Live/Dead assays
FLS were plated onto 12 mm poly-L-lysine-coated round
coverslips in 24-well tissue culture plates at 15,000 cells/
well and incubated for 24 h in DMEM complete medium
at 37°C in an atmosphere of 5% CO2. FLS were then incu-
bated for 24 h in 0.5% FBS/DMEM serum starved medium
IL-1β, 1 ng/ml.
To determine Ca2+ dependency for cell death, FLS were
treated 1 h at 37°C in 0.5% FBS/DMEM with or without
BAPTA-AM (1 μM, pH 7.4), and then treated for 24 h in
0.5% FBS/DMEM of pH 7.4 or pH 6.0. To determine if p-
ERK contributes to the cell death, FLS were treated 1 h
with PD98059 (10 μM, pH 7.4) and then 24 h in 0.5%
FBS/DMEM of pH 6.0 with PD98059 (10 μM).
Live/Dead assays (Invitrogen) were performed as de-
scribed previously [1] using a Live/Dead Viability/Cyto-
toxicity kit (L-3224; Invitrogen), 0.5 mM calcein AM,and 0.5 mM ethidium homodimer 1. Stained cells were
then mounted on slides with aqueous CMF-1 mounting
medium (Electron Microscopy Sciences, Hatfield, PA))
and imaged with an Olympus BX51 fluorescence micro-
scope with a spot camera. Image J software (NIH) was
used to merge and quantify live and dead cells. Data are
expressed as the percentage of dead cells. Each experimen-
tal condition was analyzed in three different primary cell
cultures. An average number of 713 ± 28 cells were
counted for each primary cell culture in each condition.
Statistical analysis
Data are expressed as mean ± standard error of the mean
(SEM). (Ca2+)i in response to different pH in FLS from
WT, ASIC1-/- and ASIC3-/- FLS were analyzed by
repeated-measures analysis of variance (ANOVA) followed
by Tukey’s post hoc test for differences between groups.
Differences in Ca2+imaging, western Blots, qPCR, and
Live-Dead assays for individual experiments were analyzed
with one-way ANOVA followed by Tukey’s post-hoc test
for group differences. P-values less than 0.05 were consid-
ered significant.
Results
Acidic pH increases (Ca2+)i in FLS
To determine if decreases in pH activate FLS, we per-
formed a pH-response curve from WT FLS (n = 258
cells). Figure 1A and B shows the traces of all cells aver-
aged across time from WT FLS normalized to pH 7.4.
When compared to responses at pH 7.4, pH 5.0 pro-
duced the maximal increases in (Ca2+)i (944 ± 53 arbi-
trary units). Increases in (Ca2+)i at increasing pH were
progressively smaller, with pH 5.5 showing near peak re-
sponse (938 ± 64), pH 6.0 showing a moderate response
(420 ± 57), and pH 6.8 showing minimal responses (82 ±
23) (Figure 1C).
ASIC1 and ASIC3 contribute to acidic pH-induced (Ca2+)i
increase
To determine the contribution of ASIC3-/- and ASIC1-/-
to the increases in (Ca2+)i, we performed a pH-dose
response curve in FLS from ASIC3-/- (n = 103 cells) and
ASIC1-/- (n = 198 cells) mice. Figure 1A and B shows the
traces of all cells averaged across time from ASIC3-/- and
ASIC1-/- FLS in comparison to WT FLS analyzed under
the same conditions. As individual cells show a variation
in intensity, the response from knockouts was normalized
to peak response observed in WT FLS at pH 5.0. As
shown in Figure 1C there was a significant reduction in
(Ca2+)i intensity at all pH’s tested in both ASIC3-/- and
ASIC1-/- FLS.
The contribution of intracellular or extracellular Ca2+
to the increases in (Ca2+)i produced by decreases in pH
was then examined by evaluating decreasing pH in WT
Figure 1 Ca2+ imaging determines the responses of (Ca2+)i to acidic pH in fibroblast-like synoviocytes (FLS). (Ca2+)i intensity was calculated
for each pH over a 150-s application and normalized as a percent change to the response to pH 7.4. (A) (Ca2+)i intensity normalized to pH 7.4 for
decreasing pH concentrations in wild-type (WT) and acid-sensing ion channel (ASIC3-/-) FLS. Notice a progressive increase in (Ca2+)i intensity with
decreasing doses of pH. (Ca2+)i intensity from ASIC3-/- run simultaneously showed reduced (Ca2+)i intensity with acidic pH. (B) (Ca2+)i intensity
normalized to pH 7.4 for decreasing pH concentrations in WT and ASIC1-/- FLS. (Ca2+)i intensity from ASIC1-/- FLS run simultaneously showed
reduced (Ca2+)i intensity with acidic pH. (C) Data for ASIC3-/- and ASIC1-/- were normalized to the (Ca2+)i of WT cells at pH 5.0 to control for variability
between cells and between days. A dose-dependent increase in (Ca2+)i occurred in both WT, ASIC3-/- and ASIC1-/- FLS. However, when compared to
WT FLS, ASIC3-/- and ASIC1-/- FLS showed significantly reduced (Ca2+)i at all pH’s tested when compared to WT FLS (*P <0.05). (D) In WT FLS,
replacement of the extracellular bath with a Ca2+-free medium had no effect on the increases in (Ca2+)i to acidic-pH. Blockade of (Ca2+)i stores with
cyclopiazonic acid (CPA) (30 μM) completely abolished the (Ca2+)i increases produced by acidic pH (*P <0.05). (E) (Ca2+)i in FLS from people with
rheumatoid arthritis show an increase in response to pH 6.0 when compared to responses at pH 7.4 (RA control). This increase in (Ca2+)i response to
pH 6.0 is significantly reduced by the non-specific ASIC blocker amiloride (500 μM) (P <0.05).
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tion of Ca2+ stores with the sarco-endoplasmic reticulum
Ca2+-ATPase (SERCA) inhibitor, CPA (n = 187 cells).
Similar increases in (Ca2+)i occurred in WT FLS with
and without extracellular Ca2+ in the bath (Figure 1D).
On the other hand, pretreatment using CPA completely
abolished the increases in (Ca2+)i produced by acidic
pH (Figure 1B). Thus, the (Ca2+)i increases in response
to decreases in pH through ASICs occur by release from
(Ca2+)i stores.
To confirm that human FLS also respond to acidic pH
in an ASIC-dependent manner, we examined the (Ca2+)i
intensities of RA FLS after treatment with pH 6.0 with
and without the non-selective ASIC blocker amiloride
(100 μM n= 368 cells; 250 μM n= 322 cells; 500 μM
n = 304 cells; controls, n = 326 cells). pH 6.0 signifi-
cantly increased (Ca2+)i intensity in RA FLS (Figure 1E).
Pre-treatment of the FLS with amiloride reduced this in-
crease in (Ca2+)i in a dose-dependent manner (Figure 1C).
A significant reduction in the amplitude of pH 6.0-induced
(Ca2+)i response occurred with 500 μM amiloride
(P <0.05). Thus, ASICs mediate (Ca2+)i increases in-
duced by acidic pH.Acidic pH decreases p-ERK protein expression in FLS
MAPKs play a significant role in mediating the inflam-
matory response by synoviocytes [16-20]. Therefore, we
tested if MAPKs were modulated by acidic pH using
western blot analysis. WT FLS were incubated in
pH 6.0, and compared to pH 7.4, (WT, n = 9 prepara-
tions/condition). Unexpectedly, p-ERK protein expres-
sion significantly decreased 15 minutes after exposure
to pH 6 in WT FLS when compared to the response at
pH 7.4 (P <0.05) (Figure 2A and B). No changes were
observed in total ERK, or in p-JNK, JNK, p-p38, or p-38
(Figure 2A and B).
We then examined the contribution of ASICs to the
acid-induced decrease in p-ERK using ASIC3-/- (n = 9/
condition) and ASIC1-/- FLS (n = 9/condition). The de-
crease in p-ERK expression induced by pH 6.0 did not
occur in ASIC3-/- FLS and was significantly greater than
WT FLS treated with pH 6.0 (P <0.05) (Figure 2C). On
the other hand, p-ERK expression significantly decreased
in ASIC1-/- FLS (Figure 2D). This decrease was similar to
that observed in WT FLS treated with pH 6.0 (P >0.05).
Thus, the decreases in p-ERK induced by acidic pH
require ASIC3, but not ASIC1.
Figure 2 Western blot analysis determines the responses of mitogen-activated protein kinases (MAPKs) after incubation in pH 6.0 or
7.4 in wild-type (WT), acid-sensing ion channel (ASIC3)-/- and ASIC1-/- fibroblast-like synoviocytes (FLS). (A) Representative western blots
for extracellular signal-regulated kinase (ERK), p-ERK, p-p38, p-38, c-Jun N-terminal kinase (JNK), p-JNK and actin treated with pH 7.4 or pH 6.0. Blots
were always run with pH 7.4 or pH 6.0 simultaneously. Notice the decreases in p-ERK with pH 6.0 when compared to pH 7.4. The bands that were
quantified for each protein are highlighted with an arrow and are previously described by us [31]. (B) WT FLS: density of the individual bands was
taken using Image J software and pH 6.0 was normalized to pH 7.4; pH 6.0 and pH 7.4 were always run simultaneously on the same blots to
facilitate comparison between groups. Expression values of 1.0 represent no change, <1.0 represent a decrease in expression, and > 1.0 represent
an increase in expression. p-ERK protein expression significantly decreased after exposure to pH 6.0 in WT FLS when compared to the response at
pH 7.4 (*P <0.05). (C) ASIC3-/- FLS: p-ERK protein expression was significantly greater 15 minutes after exposure to pH 6.0 in ASIC3-/- FLS when
compared to WT FLS (+P <0.05). (D) ASIC1-/- FLS: p-ERK protein expression significantly decreased after exposure to pH 6 in ASIC1-/- FLS when
compared to the response at pH 7.4 (*P <0.05), and was similar to the decreased expression observed in WT FLS.
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As acidic pH increases (Ca2+)i and decreases p-ERK, we
tested if blockade of (Ca2+)i stores prevented the de-
crease in p-ERK expression in WT FLS (n = 9 prepara-
tions/condition). Pretreatment of FLS with CPA (30 μM)
prior to and during application of pH 6.0 prevented the
decrease in p-ERK in WT FLS (Figure 3A) (P <0.05).
There were no changes in ERK expression with CPA
treatment. As protein phosphatase 2A (PP2A) can
modulate ERK activity [27] and is activated by increases
in (Ca2+)i, we then determined if PP2A blockade pre-
vents the acidic pH-induced decreases in p-ERK. Inhib-
ition of PP2A with fostriecin (FOS) (100 and 1,000 nM)
dose-dependently prevented the decrease in p-ERK in
WT FLS treated with pH 6.0 (Figure 3B). A significant
difference from those treated with 1,000 nM FOS oc-
curred when compared to control FLS not treated with
FOS (P <0.05).
Effects of the IL-1β on pH-induced changes in FLS
Previous studies show an upregulation of ASICs after in-
flammation in sensory neurons [4,32,33]; however, whetherthis upregulation occurs in other cells like FLS is unknown.
To mimic the inflammatory conditions observed in vivo,
we incubated FLS with the inflammatory cytokine IL-1β
and examined expression of ASIC3 and ASIC1 mRNA
using qPCR (n = 4 preparations/group). There was a signifi-
cant increase in expression of ASIC3 mRNA in FLS treated
with IL-1β when compared to control FLS (P <0.05). In
contrast, there was a simultaneous decrease in expres-
sion of ASIC1 in WT FLS treated with IL-1β (Figure 4A)
(P <0.05). Thus, IL-1β significantly increased expression
of ASIC3 in FLS.
To determine whether there was enhanced (Ca2+)i in
WT FLS sensitized by IL-1β we incubated FLS in IL-1β
followed by exposure to pH 6.0 (n = 112 cells); all re-
sponses were normalized to responses to pH 7.4 in the
same cells. FLS exposed to the inflammatory mediator
IL-1β demonstrated a significantly greater increase in
(Ca2+)i intensity to pH 6.0 when compared to cells not
treated with IL-1β (Figure 4B)(P <0.05). Thus, IL-1β
enhanced the acid-induced increase in (Ca2+)i.
To determine whether acid-induced decreases in
p-ERK are modified in cells sensitized by IL-1β, we
Figure 3 Western blot analysis determines the responses of
extracellular signal-regulated kinase (ERK), p-ERK and in
wild-type (WT) fibroblast-like synoviocytes (FLS) to blockade of
(Ca2+)i with cyclopiazonic acid (CPA) and of protein
phosphatase 2A (PP2A) with fostriecin (FOS). Responses after
incubation in pH 6.0 were normalized to pH 7.4. (A) Pretreatment of
WT FLS with CPA (30 μM) prior to application of pH 6.0 prevented
the decrease in p-ERK when compared to WT FLS not treated with
CPA (control) (P <0.05). (B) Blockade of PP2A with FOS (1000 nM)
prevented the decrease in p-ERK in WT FLS treated with pH 6.0
when compared to WT FLS without FOS treated with pH 6.0
(control) (P <0.05).
Figure 4 Effects of the inflammatory mediator IL-1β on acid-
induced changes in wild-type (WT) fibroblast-like synoviocytes
(FLS). (A) Real-time PCR of WT FLS determined the expression of
acid-sensing ion channel (ASIC)1 and ASIC3 after incubation with or
without IL-1β at pH 7.4. There was a significant increase in expression
of ASIC3 mRNA and a decrease in expression of ASIC1 mRNA in the
group treated with IL-1β when compared to WT FLS not treated with
IL-1β (P <0.05). (B) Ca2+ imaging determined (Ca2+)i in WT FLS treated
with IL-1β followed by exposure to pH 6.0 and normalized to
responses at pH 7.4. WT FLS incubated with IL-1β showed greater
increases in (Ca2+)i intensity when compared to WT FLS not treated
with IL-1β (P <0.05). (C) Western blot analysis determined the
acid-induced responses of extracellular signal-regulated kinase (ERK)
and p-ERK in WT FLS treated with IL-1β. After exposure to pH 6.0,
p-ERK expression was significantly higher in WT FLS with IL-1β when
compared to that in WT FLS without IL-1β (P <0.05).
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FLS treated with IL-1β (n = 9 preparations/condition).
p-ERK expression in response to pH 6.0 was significantly
higher in WT FLS treated with IL-1β, when compared
to that observed in WT FLS without IL-1β (Figure 4C)
(P <0.05). The role of ASICs in the p-ERK changes was
then explored using ASIC1-/- and ASC3-/- FLS. Interest-
ingly, a significant decrease in p-ERK in response to
pH 6.0 occurred after pre-treatment with IL-1β in both
ASIC1-/- (0.16 ± 0.02, n = 9) FLS and ASIC3-/- (0.26 ±
0.05, n = 9) FLS (P <0.05). No changes in ERK (Figure 4C),
JNK, p-JNK, p38, or p-p38 (data not shown) were
observed in WT, ASIC3-/- or ASIC1-/- FLS treated with
IL-1β and pH 6.0. Thus, the enhanced p-ERK expression
observed in cells sensitized by IL-1β was mediated by
ASIC1 and ASIC3.
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As our prior study in ASIC3-/- mice showed increases in
IL-6, MMP-3 and MMP-13 gene expression in the ankle
joint of arthritic mice when compared to WT mice [1],
we tested whether acidic pH and ASIC3 modulate gene
expression of these inflammatory mediators in FLS. In
WT FLS treated with IL-1β, there was a significant in-
crease in mRNA expression for IL-6, MMP-3 and
MMP-13 compared to WT FLS without IL-1β treat-
ment. FLS treated with pH 6.0 showed no difference
from those treated with pH 7.4, with or without IL-1β.
ASIC3-/- FLS showed similar increases in mRNA ex-
pression of IL-6, MMP-3 and MMP-13 after exposure to
IL-1β and were not significantly different from WT FLS
(Table 1). Thus, acidic pH and ASIC3 do not modulate
the enhanced expression of IL-6, MMP-3 and MMP-13
induced by IL-1β.
Regulation of apoptosis by acidic pH
We previously showed that pH 6.0 in combination with
IL-1β enhanced synoviocyte cell death in FLS from WT
mice when compared to IL-1β alone, pH 6.0 alone, or
pH 7.4, and this enhanced cell death depended on
ASIC3 [14]. As increases in (Ca2+)i can induce cell
death, and ASIC3 mediates the acid-induced increases in
(Ca2+)i, we tested whether the acid-induced cell death
depends on (Ca2+)i in WT FLS. Representative images
in Figure 5 show that cell death increased in WT FLS
exposed to pH 6.0 and IL-1β when compared to those
exposed to pH 7.4 with and or without IL-1β. After
exposure of WT FLS to IL-1β and pH 6.0, there were
significantly fewer dead cells in the group incubated with
BAPTA-AM to chelate (Ca2+)i when compared to
vehicle (Figure 5C,D,G). No changes in cell death
occurred in FLS treated with pH 7.4 with or without
IL-1β (Figure 5A,B,G,H).
As we showed that acid-induced decreases in p-ERK
are modulated by increases in (Ca2+)i, and prior studies
show that inhibiting ERK attenuates cell death [25], weTable 1 Real-time PCR determines the gene expression of cyt
pH 6.0 or 7.4 with or without IL-1β
Cytokine Il-1b
treatment
pH 7.4
WT
IL-6 (-) 0.0018 ± 0.0009
(+) 0.0886 ± 0.0218
MMP-3 (-) 0.0307 ± 0.0042
(+) 1.7975 ± 0.7027
MMP-13 (-) 0.0642 ± 0.0062
(+) 1.5977 ± 0.4506
mRNA expression of IL-6, metalloproteinase (MMP)-3 and MMP-13 all significantly in
ion channel (ASIC3)-/- FLS treated with IL-1β when compared to FLS without IL-1β.
treated pH 7.4, and there was no difference between WT FLS and ASIC3-/- FLS. Resutested whether blockade of ERK would prevent the acid-
induced cell death. FLS treated with PD98059 displayed
significantly less death in response to IL-1β and pH 6.0
when compared to WT FLS controls (pH 6.0 + IL-1β)
(Figure 5E,F,H). No changes in cell death occurred in
FLS treated with pH 7.4 and IL-1β with or without
PD9805 (Figure 5C). Thus, (Ca2+)i and ERK modulate
the enhanced cell death that occurs in response to
acidic-pH under inflammatory conditions.
Discussion
The current study demonstrated a unique role for
ASIC3 in FLS in modulating (Ca2+)i, phosphorylation of
the MAP kinase ERK, and cell death induced by acidic
pH. Specifically, we showed that activation of ASIC3 by
acidic-pH increases (Ca2+)i in FLS, which subsequently
reduces phosphorylation of ERK and this reduced p-ERK
is prevented by blockade of PP2A. After sensitization of
FLS with IL-1β, which mimics inflammatory synovitis: 1)
acidic pH further enhances (Ca2+)i; 2) acid-induced de-
creases in p-ERK are abolished, and 3) acidic pH induces
apoptosis. The cell death that occurs in IL-1β-treated
FLS exposed to acidic pH is blocked by chelation of
(Ca2+)i, inhibition of ERK, and does not occur in
ASIC3-/- FLS [1]. Further, there is enhanced inflamma-
tion and joint degradation in ASIC3-/- mice with passive
collagen-induced arthritis (CAIA) [1]. Taken together
these data support a protective role of ASIC3 under
inflammatory conditions - activation of ASIC3 would
cause cell death and limit synovitis.
Role of ASICs in (Ca2+)i increases in FLS
Our data agree with prior studies showing that acidic
pH increases (Ca2+)i [1,9,34,35]. In agreement with our
prior study [9], ASIC3 mediates these increases. We fur-
ther show that genetic deletion of ASIC1 also reduced
the (Ca2+)i produced by acidic pH. Interestingly, previ-
ous studies show increases within the same pH range as
the present study, pH 5.5 or with pH 6.8; however directokines in WT FLS and ASIC3-/- FLS after incubation in
pH 6.0
ASIC3-/- WT ASIC3-/-
0.0007 ± 0.0002 0.0037 ± 0.0028 0.001 ± 0.0004
0.1136 ± 0.013 0.1488 ± 0.0503 0.1829 ± 0.0411
0.0180 ± 0.0060 0.0373 ± 0.0072 0.0207 ± 0.0097
1.7750 ± 0.712 1.81 ± 0.7002 1.8055 ± 0.6042
0.0677 ± 0.0308 0.0761 ± 0.006 0.0879 ± 0.0526
1.5066 ± 0.5933 1.8362 ± 0.5362 1.5015 ± 0.5819
creased in wild-type (WT) fibroblast-like synoviocytes (FLS) and acid-sensing
There were no differences between WT FLS treated with pH 6.0 and those
lts are presented as mean ± standard error of the mean.
β
β
β
β
Figure 5 Live/Dead assays determined calcium dependency and extracellular signal-regulated kinase (ERK) contribution to cell death
induced by pH 6.0 with IL-1β. The number of dead fibroblast-like synoviocytes (FLS) and the number of live FLS were counted to obtain the
percent dead. (A-F) Representative images from FLS stained using a Live/Dead Viability/Cytotoxicity kit. Live cells were stained with calcein AM
(green), dead cells were stained with ethidium homodimer (red). (A and B) Show images of FLS treated by pH 7.4 without or with IL-1β,
respectively. (C and D) Show images of FLS treated by pH 6.0 and IL-1β without or with intracellular calcium chelating agent (BAPTA, 1 μM),
respectively; (E and F) show images of FLS treated by pH 6.0 and IL-1β without or with inhibitor of ERK (PD98059,10 μM), respectively.
(G) Quantitative analysis shows approximately 30% dead FLS after treatment with pH 6.0 and IL-1β, which was significantly greater than FLS
treated with pH 6.0 and IL-1β with BAPTA, and pH 7.4 and IL-1β with and without BAPTA (*P <0.01). (H) Quantitative analysis shows approximately
30% dead FLS after treatment with pH 6.0 and IL-1β, which was significantly greater than FLS treated with pH 6.0 and IL-1β with PD98059 (10 μM), and
FLS with or without IL-1β and pH 7.4 (*P <0.001). Data are mean ± standard error of the mean.
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pH was not previously examined, and these studies were
done from FLS taken from animals with CAIA [35,36]. In
the current study we did not eliminate all (Ca2+)i increases
in FLS from ASIC3-/- or from ASIC1-/-. As ASICs form
heteromers [5,37], TRPV1 can respond to acidic pH
[38,39], and a G-proton-sensing acid channel was previ-
ously identified in FLS [40], it is likely that removal of any
one channel would not eliminate the acid-response. The
overall abundance of TRPV1 (transient receptor potentialcation channel vanilloid 1) is relatively low in comparison
to ASIC3 in FLS from WT mice [9] suggesting a larger
contribution of proton response occurs for ASIC. Interest-
ingly, capsaicin-evoked increases in (Ca2+)i were actually
reduced at pH 6.8 suggesting another channel or process
inhibits the TRPV1 channel. Since each ion channel might
have different intracellular targets, their response to acid
could be unique. Thus, ion channels located on FLS can
control levels of (Ca2+)i and are activated and modulated
by decreases in pH.
BA
Figure 6 A schematic of the role of acid-sensing ion channel
(ASIC)1 and ASIC3 involved in synoviocyte function under normal
and inflammatory conditions. (A) This diagram shows fibroblast-like
synoviocytes (FLS) under normal non inflamed conditions. Extracellular
protons (H+, acidic pH) activate the ASIC3 and ASIC1 that increase
calcium release from intracellular stores. The increases in intracellular
calcium through ASIC3 activate protein phosphatase 2A (PP2A) which
subsequently dephosphorylates extracellular signal-regulated kinase
(ERK). This reduction in phosphorylation of ERK counteracts the
increases in intracellular calcium so that there is no cell death of FLS.
(B) Under inflammatory conditions, FLS are exposed to inflammatory
mediators, such as IL-1β as well as an acidic environment. The
combination of these two factors results an enhanced response
and cell death. IL-1β increases expression of ASIC3 and decreases
expression of ASIC1 results in ion channels with a greater proportion
of ASIC3 on FLS to sense the increased protons from the acidic
environment. Activation of ASIC3 by protons would then result in
enhanced calcium release intracellularly. IL-1β by itself can modulate
calcium and can enhance phosphorylation of ERK. This enhanced
intracellular calcium by activation of ASIC3 and IL-1β, along with
enhanced phosphorylation of p-ERK by activation of IL-1β receptor
activation shifts the balance of calcium and p-ERK to favor cell death.
Thus, under inflammatory conditions, decreases in pH activate ASIC3 to
produce cell death.
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Decreased ERK phosphorylation in response to acidic
pH in WT FLS was surprising, as MAPKs enhance in-
flammatory cytokine expression in FLS [16-20]. Synovio-
cytes are key players in the production of inflammatory
mediators (for example, IL-6, TNF, MMP), which subse-
quently enhance the inflammatory process and joint
damage [13-17]. Prior studies showed that increased
(Ca2+)i enhanced expression of the catalytic subunit of
PP2A which decreased ERK phosphorylation [27]. We
confirmed the role of calcium and PP2A by showing that
the decrease in p-ERK is reduced by blockade of PP2A
and (Ca2+)i. It is possible that the changes in p-ERK that
occur by blockade of PP2A are the result of a direct
action of PP2A on p-ERK changes or a parallel pathway
that results in increased ERK.
Effects of acidic pH under inflammatory conditions
The current study shows differences in response to
acidic pH in FLS treated with IL-1β, including enhanced
(Ca2+)i, no changes in p-ERK, and cell death. Exposure
to inflammatory mediators such as IL-1β can be used to
mimic the inflammatory condition. We recognize there
are a number of other key mediators present in arthritic
joints, for example, TNF and IL-6, and future experi-
ments should examine their effects on ASICs.
Our prior study in ASIC3-/- mice with CAIA showed
enhanced swelling as well as enhanced IL-6, MMP-3 and
MMP-13 expression in the joint tissue [1] suggesting that
ASIC3 might reduce gene expression of these inflamma-
tory mediators. Although IL-1β increased expression of
IL-6, MMP-3 and MMP-13 in WT FLS, these changes
were similar after application of acidic pH and in ASIC3-/-
FLS. Thus, we conclude that the enhanced expression of
inflammatory mediators in ASIC3-/- mice results from
excess synoviocyte proliferation that would normally be
prevented in WT mice by the activation of ASIC3 on FLS
in the acidic environment of an inflamed joint.
Synovial intimal lining hyperplasia is a hallmark of
RA and synoviocytes release inflammatory cytokines and
MMPs contributing to the inflammation and joint destruc-
tion [20,41]. Increasing synoviocyte cell death during
synovitis might be a mechanism to control inflammatory
joint disease progression. For example, a prior study that
expressed human calcineurin binding protein 1 in synovio-
cytes of mice with CAIA showed enhanced cell death and
reduced cytokine and MMP expression [42]. In contrast
the endogenous substance vascular endothelial growth
factor (VEGF) protects against synoviocyte cell death, is
increased in synovial fluid from individuals with RA [43],
and blockade of VEGF reduces disease severity in mice
with CAIA and enhances cell death in cultured synovio-
cytes [44]. Thus, we propose that ASIC3 plays a role in
limiting synovitis by inducing cell death under conditionsof inflammation where the pH of the joint is reduced; this
could be a normal healthy response to joint inflammation.
Our prior work shows that ASIC3-/- mice have en-
hanced inflammation and joint degradation, and sensitiz-
ing FLS with the inflammatory mediator IL-1β results in
cell death to pH 6 that requires ASIC3 [1]. The current
study showed that this IL-1β-acid-induced cell death of
FLS requires (Ca2+)i increases and activation of ERK. This
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cause cell death in a variety of cell types including neu-
rons, cancer, chondrocytes and macrophages [23-26] - we
now show that ERK plays a role in cell death of synovio-
cytes. In contrast to our study, RA FLS stimulated with
VEGF, which protects against cell death, increases p-ERK
and this increase in p-ERK is blocked by inhibition of
VEGF [45]. ERK activation in synoviocytes could be
dependent on the state of the cell, the location of ERK
within a cell compartment, the cell surface and intracellu-
lar pathways that are connected to ERK, or the ERK
subtype activated.Conclusions
Inflammation, joint damage, and pain are critical com-
ponents of RA. The current study suggests that activa-
tion of ASIC3 on FLS can modulate inflammation by
enhancing synoviocyte cell death and limit synovitis.
Thus ASIC3 could be a therapeutic target to control
disease progression. In contrast, our previously pub-
lished work consistently shows that ASIC3 plays a role
in the transmission of nociceptive (painful) information
in animal models of musculoskeletal pain where there
are reduced pain behaviors in ASIC3-/- mice or down-
regulation of ASIC3 in peripheral neurons [1-3,6-8].
Thus, ASIC3 located on nociceptors innervating in-
flamed tissue appears to produce pain-behaviors while
simultaneously through its location on synoviocytes
reduces inflammation by causing synoviocyte cell death.
Future studies should determine if alterations in ASIC3,
activation and blockade, have differential effects in WT
animals with inflammatory arthritis.
In normal resting FLS, decreases in pH activate ASIC3
to increase (Ca2+)i activating PP2A, which dephosphory-
lates ERK and there is no cell death (Figure 6). Decreases
in pH also activate ASIC1 to increase (Ca2+)i. In synovitis,
inflammatory mediators are released that can activate
intracellular pathways to increase expression of ASIC3,
decrease expression of ASIC1, increase (Ca2+)i, and in-
crease phosphorylation of ERK. The consequence of this is
an amplified response to acidic pH to result in cell death.
Thus, decreases in pH under inflammatory conditions play
a protective role by activating ASIC3 to limit synovitis and
could be a potential new therapeutic target.
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